Steffen Mueller is a

virologist Virology is the scientific study of biological viruses. It is a subfield of microbiology that focuses on their detection, structure, classification and evolution, their methods of infection and exploitation of host cells for reproduction, thei ...

and was assistant professor at Stony Brook University in New York. Mueller received his

Ph.D. A Doctor of Philosophy (PhD, Ph.D., or DPhil; Latin: or ') is the most common degree at the highest academic level awarded following a course of study. PhDs are awarded for programs across the whole breadth of academic fields. Because it is ...

in molecular microbiology from Stony Brook University in 2002 in the laboratory of Eckard Wimmer. Mueller is a co-developer of the platform technology dubbed ''SAVE'' (Synthetic Attenuated Virus Engineering), a method to produce weakened synthetic viruses that are permanently prevented from regaining

virulence Virulence is a pathogen's or microorganism's ability to cause damage to a host. In most, especially in animal systems, virulence refers to the degree of damage caused by a microbe to its host. The pathogenicity of an organism—its ability to ...

. The method may hold the key to a new class of antiviral, so-called live, or

attenuated vaccine An attenuated vaccine (or a live attenuated vaccine, LAV) is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less ...

s. Mueller is co-founder and Chief Scientific Officer o
Codagenix Inc.
a New York-based biotechnology company engaged in the development of vaccines.

References

{{DEFAULTSORT:Mueller, Steffen American virologists Living people Year of birth missing (living people)